|
|
|
Volumn 10, Issue 3 Suppl B, 2004, Pages
|
|
Clinical update on alefacept: consideration for use in patients with psoriasis.
a
a
USA
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALEFACEPT;
HYBRID PROTEIN;
BIOLOGICAL THERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG EFFECT;
HUMAN;
IMMUNOLOGY;
INJECTION;
PSORIASIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
T LYMPHOCYTE;
TREATMENT OUTCOME;
BIOLOGICAL THERAPY;
HUMANS;
INJECTIONS;
PSORIASIS;
RANDOMIZED CONTROLLED TRIALS;
RECOMBINANT FUSION PROTEINS;
T-LYMPHOCYTES;
TREATMENT OUTCOME;
|
|
EID: 4344600735
PISSN: 10834087
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (13)
|
|
References (31)
|
